The Fight Against Pneumonia and Antibiotic Resistance: Vaxdyn and the K-Vax Vaccine Candidate Against ‘Klebsiella pneumoniae’

by Asebio

2 months ago
K-Vax vaccine, Klebsiella pneumoniae, pneumonia

On the occasion of World Pneumonia Day, we interviewed Juanjo Infante, CEO of Vaxdyn, a biotech company developing the K-Vax vaccine candidate against Klebsiella pneumoniae, which is responsible for o...

Pneumonia contributes to 40.6% of deaths in children under five, says a study by the CHAMPS network

by ISGlobal - Instituto de Salud Global de Barcelona

12 months ago
red CHAMPS, pneumonia, malaria

Another study by CHAMPS concludes that 98.9% of malaria deaths could be prevented through enhanced access to malaria control measures

Pneumonia causes 2.5 million deaths around the world each year

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
respiratory infections, pneumonia, diagnosis, vaccine

nterview with Dr Catia Cilloniz, a microbiologist and doctor of medicine at the applied research group on respiratory infections and critical illness at Hospital Clínic de Barcelona, and leader of th...

Scientific publications: CD4 and CD8 lymphocytes in the progression of SARS-CoV-2 pneumonia

by Instituto de Investigación e Innovación Parc Taulí

4 years ago
immune system, lymphocytes, pneumonia, I3PT, covid-19

On November 9, the magazine Viruses published scientific article fruit of the Parc Taulí's first own research project on COVID-19. The following I3PT researchers took part in the study: Joan Calve...

Interferon, the key to many of the worst cases of COVID-19 in young people

by Hospital Universitari de Bellvitge

4 years ago
Interferon, young people, covid-19, pneumonia, cytokine, antibodies, genomics

The international consortium Covid Human Genetic Effort has discovered mutations in eight genes involved in the interferon signalling pathway, the first element in the antiviral response, in young ...

Nine Million Children Could Die in a Decade Unless World Acts on Pneumonia, Leading Agencies Warn

by ISGlobal - Instituto de Salud Global de Barcelona

5 years ago
childhood pneumonia, vaccines, Pneumonia

Today starts the first ever global forum on childhood pneumonia in Barcelona, organised by the Barcelona Institute for Global Health together with eight international entities

One child dies of pneumonia every 39 seconds

by ISGlobal - Instituto de Salud Global de Barcelona

5 years ago
child, pneumonia, virus, infectious diseases

Pneumonia – a preventable disease – kills more children than any other infection

IDIVAL patents a multivalent vaccine against listeriosis, tuberculosis and pneumonia

by Instituto de Investigación Marqués de Valdecilla

5 years ago
vaccine, listeriosis, tuberculosis, pneumonia, infections

After the last outbreak of listeriosis occurred in Spain, the bacterium Listeria monocytogenes, has established itself in Spain as one of the pathogens causing more virulent food infections.

CRG projects have been awarded ERC Proof of Concept grants

by Centre for Genomic Regulation

6 years ago
breast cancer, pneumonia, IMPACCT, MycoVAP

IMPACCT and MycoVAP projects both will receive ERC PoC grants to explore potential clinical applications of their recent results on breast cancer and pneumonia respectively.

High incidence of 'A. baumannii' resistant to all antibiotics among patients with ventilator-associated pneumonia

by ISGlobal - Instituto de Salud Global de Barcelona

7 years ago
Acinetobacter baumanniibacteria, antibiotics, pneumonia

A new study shows there is a high incidence of Acinetobacter baumanniibacteria that are resistant to all existing antibiotics among isolates collected from patients with ventilator-associated pneumoni...

IDIBAPS researchers review the latest advances on community-acquired pneumonia

by IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer

10 years ago
community-acquired pneumonia, pneumonia

The review published in The Lancet has been prepared by making a systematic search of the most relevant and recent scientific publications that focus on community-acquired pneumonia. The three major c...

The use of anti-inflammatory drugs significantly reduces treatment failure in severe pneumonia

by Fundació Clínic per a la Recerca Biomèdica

10 years ago
Pneumonia

The use of corticosteroids, a group of anti-inflammatory drugs, along with antibiotics, significantly reduces treatment failure among patients with severe community-acquired pneumonia from 31% to 13 %...